XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)    
Product revenue $ 8,727,238 $ 8,989,520
Cost of goods sold 2,519,641 2,115,910
Gross profit 6,207,597 6,873,610
Operating expenses    
Research and development, net of grant income 1,662,925 2,246,911
Selling, general and administrative 8,431,880 9,283,067
Total operating expenses 10,094,805 11,529,978
Loss from operations (3,887,208) (4,656,368)
Other income (expense)    
Interest expense, net (605,134) (6,653)
Gain (loss) on foreign currency transactions 3,013,984 (1,425,690)
Total other income (expense), net 2,408,850 (1,432,343)
Loss before benefit from income taxes (1,478,358) (6,088,711)
Benefit from income taxes 0 0
Net loss attributable to common stockholders $ (1,478,358) $ (6,088,711)
Basic net loss per common share $ (0.02) $ (0.11)
Diluted net loss per common share $ (0.02) $ (0.11)
Weighted average number of shares of common stock outstanding, basic 60,731,929 54,434,609
Weighted average number of shares of common stock outstanding, diluted 60,731,929 54,434,609
Comprehensive loss:    
Net loss attributable to common stockholders $ (1,478,358) $ (6,088,711)
Other comprehensive income (loss):    
Foreign currency translation adjustment, net of tax (2,736,354) 1,223,175
Comprehensive loss $ (4,214,712) $ (4,865,536)